MediPal Holdings Corporation Announces Consolidated Results for the First Quarter of the Fiscal Year Ending March 31, 2020; Provides Earnings Guidance for the Interim Period and Full Year of Fiscal Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2020
July 30, 2019
Share
MediPal Holdings Corporation announced consolidated results for the first quarter of the fiscal year ending March 31, 2020. For the quarter, the company reported net sale of JPY 810,928 million against JPY 803,243 million a year ago. Operating profit was JPY 12,187 million against JPY 11,572 million a year ago. Profit attributable to owners of parent was JPY 7,869 million against JPY 8,112 million a year ago. Earnings per basic share was JPY 35.37 against JPY 33.30 per share a year ago. Earnings per diluted share was JPY 36.13 against JPY 34.04 per share a year ago.
The company provided earnings guidance for the interim period and full year of fiscal year ending March 31, 2020. For the interim period, the company reported net sale of JPY 1,638,000 million, operating profit was JPY 24,100 million, profit attributable to owners of parent was JPY 14,800 million and earnings per basic share was JPY 66.53 per share.
For the fiscal year ending March 31, 2020, the company reported net sale of JPY 3,242,000 million, operating profit was JPY 51,000 million, profit attributable to owners of parent was JPY 38,800 million and earnings per basic share was JPY 174.41 per share.
The company provided dividend guidance for the second quarter and full year of fiscal year ending March 31, 2020. For the second quarter the company provided dividend guidance of JPY 18 per share against JPY 20 per share a year ago.
For the fiscal year ending March 31, 2020, the company provided dividend guidance of JPY 20 per share against JPY 20 per share a year ago.
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
MediPal Holdings Corporation Announces Consolidated Results for the First Quarter of the Fiscal Year Ending March 31, 2020; Provides Earnings Guidance for the Interim Period and Full Year of Fiscal Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2020
MEDIPAL HOLDINGS CORPORATION 
